Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02336360 · ClinicalTrials.gov registry record · Phase 1
Augmenting Flortaucipir Dosimetry Estimates
A Phase 1 study, sponsored by Avid Radiopharmaceuticals.
- Completed
- Registry status
- Phase 1
- Development phase
- 6
- Enrollment target
NCT02336360 is a Phase 1 study that has completed, run by Avid Radiopharmaceuticals. The registered enrollment target is 6 participants.
The verdict
NCT02336360, a Phase 1 study, has completed, sponsored by Avid Radiopharmaceuticals.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 6 participants
- Enrollment target
Study Summary
This study will obtain data from urine in subjects administered flortaucipir in an Avid-sponsored study to augment the calculation of radiation dosimetry estimates.
Interventions
- DRUG Flortaucipir F18
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2015-01 |
| Est. Completion | 2015-06 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02336360
The ClinicalTrials.gov registry entry for NCT02336360 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Avid Radiopharmaceuticals, which has 42 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Flortaucipir F18 is the first listed.
NCT02336360 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02336360 about?
NCT02336360 is a clinical study titled "Augmenting Flortaucipir Dosimetry Estimates". This study will obtain data from urine in subjects administered flortaucipir in an Avid-sponsored study to augment the calculation of radiation dosimetry estimates.
What is the current status of trial NCT02336360?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 6 participants. The study started on 2015-01. Estimated completion is 2015-06.
What interventions are being tested in trial NCT02336360?
The interventions under investigation include: Flortaucipir F18 (DRUG).
Who is sponsoring clinical trial NCT02336360?
This trial is sponsored by Avid Radiopharmaceuticals, which has 42 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.